{
  "links": "https://www.ycombinator.com/companies/signatur-biosciences",
  "name": "Signatur Biosciences",
  "headline": "Simple tests for complex diseases.",
  "batch": "S22",
  "description": "We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.",
  "activity_status": "Active",
  "website": "https://www.signatur.bio/",
  "founded_date": 2022.0,
  "team_size": 5.0,
  "location": "London, United Kingdom",
  "group_partner": null,
  "group_partner_yc": null,
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:biotech; industry:healthcare; industry:diagnostics",
  "founders": [
    {
      "name": "John Goertz, Founder",
      "description": "Co-founder, CSO, and PCRchitect at Signatur Biosciences. I teach machine learning to molecules to expand the range of diseases we can diagnose with PCR. NIH F32 Postdoctoral Fellow in the the Stevens Group at Imperial College London; PhD Bioengineering from University of Maryland, College Park; BSc Physics and Cell & Molecular Biology from Seattle University. When I’m not programming DNA, I’m cooking, running, or doing martial arts (Danzan-Ryu Japanese Jujitsu).",
      "linkedin": "https://www.linkedin.com/in/johngoertz/"
    },
    {
      "name": "Celestin de Wergifosse, Founder",
      "description": "Co-founder and CEO of Signatur Biosciences. Startups since the age of 14. First patent at 15. WIPO Best Young Inventor 2010. Twice TEDx speaker. Co-founded Young Change Maker, a social startup that highlights inspiring individuals. Co-founded and sold a company called Sauna en Bois. Bio-engineering from Imperial College London. When I don't work, I race motorcycles, climb or ski. My life-long goal is to develop biotech companies that address global issues.",
      "linkedin": "https://www.linkedin.com/in/celestin-de-wergifosse-41b9823b/"
    }
  ],
  "status": true,
  "markdown": "raw_markdown=\"[ 0 ](https://www.signatur.bio/</cart>)\\n[ Skip to Content ](https://www.signatur.bio/<#page>)\\n[ ![SIGNATUR BIO](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/479b6df6-0534-48f2-9bcf-6514954e3de2/Signatur-Biosciences-Logo-Typography.png?format=1500w) ](https://www.signatur.bio/</>)\\n[ Home ](https://www.signatur.bio/</>)\\n[ Technology ](https://www.signatur.bio/</technology>)\\n[ Team ](https://www.signatur.bio/</team>)\\n[ Careers ](https://www.signatur.bio/</careers>)\\n[ Contact ](https://www.signatur.bio/</contact>)\\nOpen Menu Close Menu\\n[ ![SIGNATUR BIO](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/479b6df6-0534-48f2-9bcf-6514954e3de2/Signatur-Biosciences-Logo-Typography.png?format=1500w) ](https://www.signatur.bio/</>)\\n[ Home ](https://www.signatur.bio/</>)\\n[ Technology ](https://www.signatur.bio/</technology>)\\n[ Team ](https://www.signatur.bio/</team>)\\n[ Careers ](https://www.signatur.bio/</careers>)\\n[ Contact ](https://www.signatur.bio/</contact>)\\nOpen Menu Close Menu\\n[ Home  ](https://www.signatur.bio/</>)\\n[ Technology  ](https://www.signatur.bio/</technology>)\\n[ Team  ](https://www.signatur.bio/</team>)\\n[ Careers  ](https://www.signatur.bio/</careers>)\\n[ Contact  ](https://www.signatur.bio/</contact>)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/5589aea4-73d4-4d95-835e-48c114cedf1c/fondo-0.jpg)\\n# Simple tests for complex diseases\\nWe’re on a mission to make precision diagnostics accessible around the planet.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/69a2197b-ac79-4d06-ac58-f84908c7f76a/trama-1.png)\\n### Our molecular technology makes diagnosing complex diseases simple. No need for laborious tests and expensive machines, our kits bring _molecular intelligence_ to widely accessible PCR equipment.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/efb9fd8f-a79a-48d7-9b08-d4ceecea878b/fondo-1-hi.png)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/89ce0e04-0efb-4904-8d7a-8e86fc1aea73/iStock-1290561148+%281%29.jpg)\\n### Traditional PCR diagnostics are limited. \\nTraditional molecular diagnosis uses a biochemical reaction known as PCR to look for one biomarker that indicates the patient has a disease.\\nTypically, PCR has been used to diagnose infectious diseases because these conditions require only one or two biomarkers to detect (e.g., viral RNA). This is how lab COVID tests work.\\nHowever, many diseases aren't that simple. The industry is turning to panels of multiple biomarkers, in particular gene expression signatures. Right now, this requires either running numerous PCR tests in parallel or upgrading to expensive, complicated machinery, like sequencers.\\nThese legacy technologies are not fit-for-purpose. Complex preparation and analysis workflows and high-tech machines increase the time and cost of diagnosis, creating a real bottleneck for precision medicine adoption and leading to underserved disease areas.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/35f48371-ac17-4062-a49d-9ef1e3b9b611/fondo-1-hi.png)\\n### We design smart PCR kits that detect gene expression signatures.\\nSignatur Biosciences’ technology expands PCR testing to a whole new range of conditions. We design smart PCR kits that can detect complex diseases as easily as a COVID test, using standard qPCR machines. Our kits seamlessly integrate into existing clinical workflows and ubiquitous laboratory instruments.\\nModern, precision diagnosis relies on patterns of biomarkers. Our **_PCRchitectur_** technology uses the molecular machinery of PCR to condense all the work of detecting and interpreting a panel of RNA biomarkers into a single test. Instead of relying on complex solutions, we seamlessly integrate with existing clinical workflows and infrastructure.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/db79947b-b9c1-4920-88cd-c215ec4dd74b/Plate+Preparation.jpg)\\n## Smarter tests. Covering more diseases. Supporting more people.\\n## Supported by:\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/0a092ae9-5a79-4dec-9c70-602f8a5d5323/1704939471421.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/ac535985-04f8-4f30-a774-2bd800476561/Innovate+UK.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/9c675e47-c546-4279-bc76-adee247a2a83/imperial-college-london5190.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/d74764dc-044c-417c-9f15-3f073efebf47/ff0391183e4fe9078cbacb7652144000.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/ff4445db-e555-43ab-a859-c658971ff1c9/fondo-8.png)\\n## Sign up with your email address to receive news and updates.\\nEmail Address\\nSign Up\\nThank you!\\n©2024 by Signatur Biosciences\\nDisclaimer: Technology in development. Not for Sale. \\n[ ](https://www.signatur.bio/<https:/www.linkedin.com/company/signatur-bio/>)[ ](https://www.signatur.bio/<https:/twitter.com/SignaturBio>)\\n\" markdown_with_citations=\" 0 ⟨1⟩\\n Skip to Content ⟨2⟩\\n ![SIGNATUR BIO⟨3⟩ ](https://www.signatur.bio/</>)\\n Home ⟨4⟩\\n Technology ⟨5⟩\\n Team ⟨6⟩\\n Careers ⟨7⟩\\n Contact ⟨8⟩\\nOpen Menu Close Menu\\n ![SIGNATUR BIO⟨3⟩ ](https://www.signatur.bio/</>)\\n Home ⟨4⟩\\n Technology ⟨5⟩\\n Team ⟨6⟩\\n Careers ⟨7⟩\\n Contact ⟨8⟩\\nOpen Menu Close Menu\\n Home  ⟨4⟩\\n Technology  ⟨5⟩\\n Team  ⟨6⟩\\n Careers  ⟨7⟩\\n Contact  ⟨8⟩\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/5589aea4-73d4-4d95-835e-48c114cedf1c/fondo-0.jpg)\\n# Simple tests for complex diseases\\nWe’re on a mission to make precision diagnostics accessible around the planet.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/69a2197b-ac79-4d06-ac58-f84908c7f76a/trama-1.png)\\n### Our molecular technology makes diagnosing complex diseases simple. No need for laborious tests and expensive machines, our kits bring _molecular intelligence_ to widely accessible PCR equipment.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/efb9fd8f-a79a-48d7-9b08-d4ceecea878b/fondo-1-hi.png)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/89ce0e04-0efb-4904-8d7a-8e86fc1aea73/iStock-1290561148+%281%29.jpg)\\n### Traditional PCR diagnostics are limited. \\nTraditional molecular diagnosis uses a biochemical reaction known as PCR to look for one biomarker that indicates the patient has a disease.\\nTypically, PCR has been used to diagnose infectious diseases because these conditions require only one or two biomarkers to detect (e.g., viral RNA). This is how lab COVID tests work.\\nHowever, many diseases aren't that simple. The industry is turning to panels of multiple biomarkers, in particular gene expression signatures. Right now, this requires either running numerous PCR tests in parallel or upgrading to expensive, complicated machinery, like sequencers.\\nThese legacy technologies are not fit-for-purpose. Complex preparation and analysis workflows and high-tech machines increase the time and cost of diagnosis, creating a real bottleneck for precision medicine adoption and leading to underserved disease areas.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/35f48371-ac17-4062-a49d-9ef1e3b9b611/fondo-1-hi.png)\\n### We design smart PCR kits that detect gene expression signatures.\\nSignatur Biosciences’ technology expands PCR testing to a whole new range of conditions. We design smart PCR kits that can detect complex diseases as easily as a COVID test, using standard qPCR machines. Our kits seamlessly integrate into existing clinical workflows and ubiquitous laboratory instruments.\\nModern, precision diagnosis relies on patterns of biomarkers. Our **_PCRchitectur_** technology uses the molecular machinery of PCR to condense all the work of detecting and interpreting a panel of RNA biomarkers into a single test. Instead of relying on complex solutions, we seamlessly integrate with existing clinical workflows and infrastructure.\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/db79947b-b9c1-4920-88cd-c215ec4dd74b/Plate+Preparation.jpg)\\n## Smarter tests. Covering more diseases. Supporting more people.\\n## Supported by:\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/0a092ae9-5a79-4dec-9c70-602f8a5d5323/1704939471421.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/ac535985-04f8-4f30-a774-2bd800476561/Innovate+UK.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/9c675e47-c546-4279-bc76-adee247a2a83/imperial-college-london5190.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/d74764dc-044c-417c-9f15-3f073efebf47/ff0391183e4fe9078cbacb7652144000.jpg)\\n![](https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/ff4445db-e555-43ab-a859-c658971ff1c9/fondo-8.png)\\n## Sign up with your email address to receive news and updates.\\nEmail Address\\nSign Up\\nThank you!\\n©2024 by Signatur Biosciences\\nDisclaimer: Technology in development. Not for Sale. \\n ⟨9⟩ ⟨10⟩\\n\" references_markdown='\\n\\n## References\\n\\n⟨1⟩ https://www.signatur.bio/</cart>:  0 \\n⟨2⟩ https://www.signatur.bio/<#page>:  Skip to Content \\n⟨3⟩ https://images.squarespace-cdn.com/content/v1/629d2964307b747833657cb6/479b6df6-0534-48f2-9bcf-6514954e3de2/Signatur-Biosciences-Logo-Typography.png?format=1500w:  ![SIGNATUR BIO\\n⟨4⟩ https://www.signatur.bio/</>:  Home \\n⟨5⟩ https://www.signatur.bio/</technology>:  Technology \\n⟨6⟩ https://www.signatur.bio/</team>:  Team \\n⟨7⟩ https://www.signatur.bio/</careers>:  Careers \\n⟨8⟩ https://www.signatur.bio/</contact>:  Contact \\n⟨9⟩ https://www.signatur.bio/<https:/www.linkedin.com/company/signatur-bio/>:  \\n⟨10⟩ https://www.signatur.bio/<https:/twitter.com/SignaturBio>:  \\n' fit_markdown='' fit_html=''",
  "generated_description": "**Company Overview: Signatur Biosciences**\n\nFounded in 2022 as part of the Y Combinator Batch S22, Signatur Biosciences is a London-based biotech startup on a mission to deliver “simple tests for complex diseases.” With a compact team of five, the company aims to revolutionize precision diagnostics, starting with a focus on breast cancer prognosis.\n\n**The Problem: Accessibility of Precision Diagnostics**\n\nCurrent diagnostic tests for guiding therapy are notoriously slow and costly. They often depend on intricate centralized facilities that can take over three weeks to deliver results, which is downright unacceptable when lives hang in the balance. Signatur recognizes that many patients—especially in underserved areas—don't have access to timely, affordable diagnostic tools. \n\n**The Solution: Smarter PCR Kits**\n\nAt its core, Signatur Biosciences leverages its innovative **PCRchitectur** technology to streamline and enhance the diagnostic process. Instead of traditional PCR tests that are limited by their need for expensive machinery and lengthy procedures, Signatur's smart PCR kits can be run on standard qPCR machines found in local hospital labs. \n\nThis means a significant reduction in turnaround time from weeks to mere days, enabling faster decision-making in treatment paths. No longer do clinicians have to sift through complex workflows or rely on numerous tests. Signatur’s kits consolidate the work of detecting and interpreting multiple RNA biomarkers into a single test, making the process more efficient and cost-effective.\n\n**A Bigger Vision**\n\nSignatur Biosciences doesn't just see itself as a player in breast cancer prognosis; its ambition is to expand the scope of PCR testing to cover a wider range of diseases, paving the way for smarter healthcare solutions that are both affordable and accessible globally.\n\nIn summary, by making precision diagnostics accessible and efficient, Signatur Biosciences stands at the forefront of modern healthcare innovation, potentially reshaping how we think about disease detection and management. \n\nFor more insights, check out their website: [Signatur Biosciences](https://www.signatur.bio/)."
}